FDA Orange Book · active-ingredient family
Sulfisoxazole
Sulfisoxazole is approved as 1 brand and 18 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:GANTRISIN · NDA 006525
1
Brand (NDA)
18
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| GANTRISIN | ROCHE | NDA 006525 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (18)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SOSOL | MK LABS | ANDA 080036 | — | Approved Prior to Jan 1, 1982 | |
| SOXAZOLE | ALRA | ANDA 080366 | — | Approved Prior to Jan 1, 1982 | |
| SULFALAR | PARKE DAVIS | ANDA 084955 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | ANI PHARMS | ANDA 080142 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | BARR | ANDA 084031 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | HEATHER | ANDA 080189 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | IMPAX LABS | ANDA 080109 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | LANNETT | ANDA 080085 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | LEDERLE | ANDA 087649 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | PHARMERAL | ANDA 084385 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | PUREPAC PHARM | ANDA 080087 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | RISING | ANDA 085628 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | ROXANE | ANDA 080082 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | VALEANT PHARM INTL | ANDA 080268 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | VITARINE | ANDA 087332 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | WATSON LABS | ANDA 085534 | — | Approved Prior to Jan 1, 1982 | |
| SULFISOXAZOLE | WEST WARD | ANDA 080379 | — | Approved Prior to Jan 1, 1982 | |
| SULSOXIN | SOLVAY | ANDA 080040 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Sulfisoxazole — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

